NASDAQ:GTH Genetron (GTH) Stock Forecast, Price & News $0.89 +0.01 (+1.43%) (As of 12:21 PM ET) Add Compare Share Share Today's Range$0.87▼$0.8950-Day Range$0.87▼$1.0652-Week Range$0.73▼$1.75Volume25,615 shsAverage Volume61,660 shsMarket Capitalization$81.79 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Genetron (NASDAQ:GTH) StockGenetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. The company has a strategic partnership with JD Health to create solutions for full-cycle cancer management. Genetron Holdings Limited was founded in 2015 and is headquartered in Beijing, the People's Republic of China.Read More Receive GTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genetron and its competitors with MarketBeat's FREE daily newsletter. Email Address GTH Stock News HeadlinesMay 31, 2023 | americanbankingnews.comGenetron (NASDAQ:GTH) Trading Down 3.3%May 24, 2023 | msn.comGenetron Health receives Nasdaq notice for non-complianceJune 5, 2023 | Edge On The Street (Ad)The Graphite Shortage Story You're Not Being ToldGraphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security. April 19, 2023 | americanbankingnews.comShort Interest in Genetron Holdings Limited (NASDAQ:GTH) Expands By 41.6%March 27, 2023 | msn.comAmerican Depositary Receipts of Asian Stocks Lower Amid Banking Sector WorriesJanuary 18, 2023 | finance.yahoo.comGenetron Health Regains Compliance With Nasdaq Minimum Bid Price RequirementDecember 28, 2022 | msn.comEarlier US Stock Market Losses Weighed on Asian EquitiesNovember 7, 2022 | finance.yahoo.comGenetron Health Announces Receipt of Notification from NasdaqJune 5, 2023 | Edge On The Street (Ad)The Graphite Shortage Story You're Not Being ToldGraphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security. October 19, 2022 | seekingalpha.comGTH Genetron Holdings LimitedOctober 12, 2022 | finance.yahoo.comGenetron Health Reports Unaudited Second Quarter 2022 Financial ResultsSeptember 20, 2022 | reuters.comGenetron Holdings LtdSeptember 2, 2022 | finance.yahoo.comGenetron Health Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special CommitteeAugust 22, 2022 | benzinga.comGenetron Health Announces Receipt of a...August 22, 2022 | nasdaq.comGenetron Health Board Receives Proposal Letter From CEO Sizhen WangAugust 19, 2022 | finance.yahoo.comStrong week for Genetron Holdings (NASDAQ:GTH) shareholders doesn't alleviate pain of one-year lossJune 15, 2022 | seekingalpha.comGenetron's Maryland lab gets CAP accreditationJune 15, 2022 | finance.yahoo.comGenetron Health Receives CAP Accreditation for its Maryland LaboratoryJune 3, 2022 | markets.businessinsider.comCOO Boosts Revenue Outlook, GTH On Watch, PHR Forecasts 27% To 29% Revenue Growth...June 2, 2022 | seekingalpha.comGenetron Holdings Limited (GTH) CEO Sizhen Wang on Q1 2022 Results - Earnings Call TranscriptJune 2, 2022 | finance.yahoo.comGenetron Health Reports Unaudited First Quarter 2022 Financial ResultsJune 1, 2022 | seekingalpha.comChina's Genetron's gene mutation test FusionScan gets CE mark in EUMay 23, 2022 | finance.yahoo.comGenetron Health to Announce First Quarter 2022 Unaudited Financial Results and Host Investor Call on June 2, 2022April 7, 2022 | stockhouse.comPublication in Clinical and Translational Medicine Demonstrates Mutation Capsule(TM)'s potential in MRD Assay DevelopmentsApril 7, 2022 | finance.yahoo.comPublication in Clinical and Translational Medicine Demonstrates Mutation Capsule™’s potential in MRD Assay DevelopmentsMarch 30, 2022 | markets.businessinsider.comIMAB On Watch, GTH Expects 2022 Revenue To Grow 10-20%, PHVS To Report HAE Trial Data In Q4March 29, 2022 | finance.yahoo.comGenetron Health Announces Unaudited Fourth Quarter and Full Year 2021 Financial ResultsSee More Headlines GTH Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GTH Company Calendar Last Earnings5/23/2021Today6/05/2023Next Earnings (Estimated)6/06/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Medical laboratories Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:GTH CUSIPN/A CIK1782594 Webwww.genetronhealth.com Phone86-10-5090-7500FaxN/AEmployees1,154Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.01 Current Ratio1.82 Quick Ratio1.71 Sales & Book Value Annual Sales$650.71 million Price / Sales0.12 Cash FlowN/A Price / Cash FlowN/A Book Value$0.88 per share Price / Book1.00Miscellaneous Outstanding Shares91,549,000Free FloatN/AMarket Cap$80.64 million OptionableNot Optionable Beta0.53 Key ExecutivesMr. Sizhen Wang (Age 46)Co-Founder, CEO & Chairman Dr. Wei-Wu He Ph.D. (Age 58)Co-Founder & Chairman Emeritus Dr. Hai Yan (Age 55)Co-Founder, Chief Scientific Officer & Director Mr. Ce Xu (Age 41)Chief Financial Officer Ms. Victoria LeiChief Operating OfficerDr. Yuchen Jiao M.D. (Age 45)Ph.D., Chief Technology Officer Mr. Yong Liang (Age 49)Chief HR Officer Dr. Yun-Fu Hu Ph.D. (Age 60)Chief Medical Officer Ms. Lily LiuChief Commercial OfficerMore ExecutivesKey CompetitorsDermTechNASDAQ:DMTKPersonalisNASDAQ:PSNLMedTech AcquisitionNASDAQ:MTACSera PrognosticsNASDAQ:SERAMDxHealthNASDAQ:MDXHView All CompetitorsInstitutional OwnershipHudson Bay Capital Management LPSold 150,037 shares on 5/16/2023Ownership: 0.536%Susquehanna International Group LLPBought 20,168 shares on 5/16/2023Ownership: 0.035%Schonfeld Strategic Advisors LLCSold 34,700 shares on 5/15/2023Ownership: 0.165%View All Institutional Transactions GTH Stock - Frequently Asked Questions How have GTH shares performed in 2023? Genetron's stock was trading at $1.12 at the start of the year. Since then, GTH shares have decreased by 21.4% and is now trading at $0.8808. View the best growth stocks for 2023 here. Are investors shorting Genetron? Genetron saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 158,600 shares, a decline of 8.3% from the April 30th total of 172,900 shares. Based on an average daily volume of 28,200 shares, the days-to-cover ratio is presently 5.6 days. Currently, 0.2% of the company's shares are short sold. View Genetron's Short Interest. When is Genetron's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 6th 2023. View our GTH earnings forecast. How were Genetron's earnings last quarter? Genetron Holdings Limited (NASDAQ:GTH) posted its quarterly earnings data on Sunday, May, 23rd. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.07) by $0.10. The firm had revenue of $14.05 million for the quarter. Read the conference call transcript. When did Genetron IPO? (GTH) raised $162 million in an initial public offering on Friday, June 19th 2020. The company issued 13,000,000 shares at a price of $11.50-$13.50 per share. Credit Suisse and CICC acted as the underwriters for the IPO and BTIG and Canaccord Genuity were co-managers. What is Genetron's stock symbol? Genetron trades on the NASDAQ under the ticker symbol "GTH." Who are Genetron's major shareholders? Genetron's stock is owned by a number of retail and institutional investors. Top institutional investors include Hudson Bay Capital Management LP (0.54%), Schonfeld Strategic Advisors LLC (0.17%) and Susquehanna International Group LLP (0.04%). How do I buy shares of Genetron? Shares of GTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Genetron's stock price today? One share of GTH stock can currently be purchased for approximately $0.88. How much money does Genetron make? Genetron (NASDAQ:GTH) has a market capitalization of $80.64 million and generates $650.71 million in revenue each year. The company earns $-117,210,000.00 in net income (profit) each year or ($1.18) on an earnings per share basis. How many employees does Genetron have? The company employs 1,154 workers across the globe. How can I contact Genetron? Genetron's mailing address is 1-2/F BUILDING 11 ZONE 1 CHANGPING DISTRICT, BEIJING F4, 102206. The official website for the company is www.genetronhealth.com. The company can be reached via phone at 86-10-5090-7500 or via email at ir@genetronhealth.com. This page (NASDAQ:GTH) was last updated on 6/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genetron Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.